Tina Barton

Chief Operating Officer - Emerging Markets Quality Trials (eMQT)

Dr. Tina Barton, COO of eMQT, is a drug development specialist with over 40 years’ experience, working in partnership to lead for success as a customer-focused senior leader. Dr. Barton provides strategic business acumen, change management and process enhancement expertise with a proven track record in driving growth, managing teams and training for the future – from large global organisations to small start-up enterprises. With a passion for transformation, Dr. Barton drove the embracement of Central Eastern European countries and now is focused on the inclusion of Sub- Saharan Africa into clinical development – bringing the miracle of development of new medicines to emerging markets and new patients. Dr. Barton holds a BSc, PhD and MBA alongside over 50 academic publications and is an Honorary Fellow, and Board Member of the Institute of Clinical Research.

Tina Barton


  • Wednesday - May 29, 2024 - 15:45

    Africa’s role in reducing clinical delays


  • Wednesday - May 29, 2024 - 16:45

    Panel Discussion: Leveraging Big Data and AI in the Era of Tech-Driven Clinical Trials: Opportunities and Ethical Dilemmas


Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now